Clinical Trial: A prospective, single-arm clinical study of IDH1 inhibitor combined with Essentiale in the treatment of IDH1-mutated cholangiocarcinoma (China)

Posted On: 2026-11-10

China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, single-arm clinical study of IDH1 inhibitor combined with Essentiale in the treatment of IDH1-mutated cholangiocarcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136253

Registration Time: 2026/11/09

Type: Interventional study

Primary Sponsor: Thrid Affiliated Hospital of Naval Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=318461

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A prospective, single-arm clinical study of IDH1 inhibitor combined with Essentiale in the treatment of IDH1-mutated cholangiocarcinoma (China)